Alain Gendron, PhD
- 2Articles
- 7.6KReads1
- 2008–2011Active
- 12Collaborators
- 30Citations2
About
Alain Gendron, PhD, has contributed to research on schizophrenia and schizoaffective disorders, focusing on the safety, tolerability, and pharmacokinetics of quetiapine formulations. Published between 2008 and 2011, the work includes clinical trials assessing high-dose quetiapine and imaging studies comparing extended-release and immediate-release forms. Collaborators frequently include Alain Labelle, David C. Mamo, Emmanuel Stip, G. William MacEwan, and Hans Eriksson.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
